SE9604341D0 - Hepta-peptide oxytocin analogue - Google Patents
Hepta-peptide oxytocin analogueInfo
- Publication number
- SE9604341D0 SE9604341D0 SE9604341A SE9604341A SE9604341D0 SE 9604341 D0 SE9604341 D0 SE 9604341D0 SE 9604341 A SE9604341 A SE 9604341A SE 9604341 A SE9604341 A SE 9604341A SE 9604341 D0 SE9604341 D0 SE 9604341D0
- Authority
- SE
- Sweden
- Prior art keywords
- pct
- moiety
- hepta
- aminoacid
- analogues
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Pregnancy & Childbirth (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (35)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9604341A SE9604341D0 (sv) | 1996-11-26 | 1996-11-26 | Hepta-peptide oxytocin analogue |
PT97946210T PT938496E (pt) | 1996-11-26 | 1997-11-21 | Misturas insecticidas sinergicas |
HR970630A HRP970630B1 (en) | 1996-11-26 | 1997-11-21 | Hepapeptide oxytocin analogues |
HU0000577A HU228568B1 (en) | 1996-11-26 | 1997-11-21 | Heptapeptide oxytocin analogues pharmaceutical compositions containing them and their use and for producing them |
US09/308,912 US6143722A (en) | 1996-11-26 | 1997-11-21 | Heptapeptide oxytocin analogues |
UA99042410A UA54459C2 (uk) | 1996-11-26 | 1997-11-21 | Аналоги гептапептиду окситоцину, спосіб їх отримання, фармацевтична композиція, спосіб її отримання, спосіб запобігання передчасним пологам |
IL12951997A IL129519A (en) | 1996-11-26 | 1997-11-21 | Potateptide analogues with antagonistic activity to oxytocin, their preparation methods, pharmaceutical compositions containing them, and their use in the manufacture of drugs |
PL97333876A PL189292B1 (pl) | 1996-11-26 | 1997-11-21 | Analog heptapeptydowy, środek farmacetyczny zawierający ten analog, zastosowanie analogu, zastosowanie środka farmacetycznego, sposób wytwarzania tego analogu oraz sposób wytwarzania środka farmacetycznego |
AU51429/98A AU713424B2 (en) | 1996-11-26 | 1997-11-21 | Heptapeptide oxytocin analogues |
CA002272990A CA2272990C (en) | 1996-11-26 | 1997-11-21 | Heptapeptide oxytocin analogues |
NZ336445A NZ336445A (en) | 1996-11-26 | 1997-11-21 | Heptapeptide oxytocin analogues |
SK704-99A SK283800B6 (sk) | 1996-11-26 | 1997-11-21 | Heptapeptidový analóg, farmaceutická kompozícia obsahujúca tento analóg, spôsob prípravy heptapeptidového analógu a jeho použitie pri príprave liečiva na redukciu alebo blokovanie kontrakcie maternicového svalu |
ZA9710518A ZA9710518B (en) | 1996-11-26 | 1997-11-21 | Oxytocin heptapeptide analogues. |
PCT/SE1997/001968 WO1998023636A1 (en) | 1996-11-26 | 1997-11-21 | Heptapeptide oxytocin analogues |
EEP199900210A EE03832B1 (et) | 1996-11-26 | 1997-11-21 | Heptapeptiidanaloogid |
RU99113364/04A RU2180668C2 (ru) | 1996-11-26 | 1997-11-21 | Гептапептидные аналоги окситоцина |
JP52460298A JP3405460B2 (ja) | 1996-11-26 | 1997-11-21 | ヘプタペプチドオキシトシン類似体 |
DE69722651T DE69722651T2 (de) | 1996-11-26 | 1997-11-21 | Heptapeptid oxytocin analogen |
EP97946210A EP0938496B1 (en) | 1996-11-26 | 1997-11-21 | Heptapeptide oxytocin analogues |
CZ0183299A CZ299532B6 (cs) | 1996-11-26 | 1997-11-21 | Heptapeptidový analog, farmaceutická kompozice obsahující tento analog, zpusob prípravy heptapeptidového analogu a jeho použití a zpusob prípravy farmaceutické kompozice obsahující tento analog |
DK97946210T DK0938496T3 (da) | 1996-11-26 | 1997-11-21 | Heptapeptidoxytocinanaloger |
AT97946210T ATE242264T1 (de) | 1996-11-26 | 1997-11-21 | Heptapeptid oxytocin analogen |
RO99-00593A RO120772B1 (ro) | 1996-11-26 | 1997-11-21 | Analogi de heptapeptidă, compoziţie farmaceutică care îi conţine şi procedeu de preparare a acestora |
TR1999/01028T TR199901028T2 (xx) | 1996-11-26 | 1997-11-21 | Heptapeptid oksitosin analoglar�. |
ES97946210T ES2203823T3 (es) | 1996-11-26 | 1997-11-21 | Analogos heptapeptidicos de oxitocina. |
BRPI9713366-3A BR9713366B1 (pt) | 1996-11-26 | 1997-11-21 | análogos de heptapeptìdeo oxitocina. |
SI9720076A SI20026B (sl) | 1996-11-26 | 1997-11-21 | Heptapeptidni analogi - antagonisti oksitocina |
KR10-1999-7004449A KR100463132B1 (ko) | 1996-11-26 | 1997-11-21 | 헵타펩티드 옥시토신 동족체 |
CN97180014A CN1129606C (zh) | 1996-11-26 | 1997-11-21 | 七肽催产素类似物 |
MYPI97005691A MY125555A (en) | 1996-11-26 | 1997-11-25 | Heptapeptide oxytocin analogues |
ARP970105543A AR008531A1 (es) | 1996-11-26 | 1997-11-26 | Análogos a heptapeptidos antagonistas de la oxitocina |
LVP-99-77A LV12350B (en) | 1996-11-26 | 1999-04-30 | HEPTAPEPHITE OXITOCIN ANALOGUE |
LT99-052A LT4650B (lt) | 1996-11-26 | 1999-05-11 | Heptapeptidiniai oksitocino analogai |
NO19992532A NO321380B1 (no) | 1996-11-26 | 1999-05-26 | Heptapeptid analog med oksytocinantagonistaktivitet, fremgangsmate ved fremstilling derav samt anvendelse derav til fremstilling av medikamenter. |
HK00101422A HK1022481A1 (en) | 1996-11-26 | 2000-03-07 | Heptapeptide oxytocin analogues |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9604341A SE9604341D0 (sv) | 1996-11-26 | 1996-11-26 | Hepta-peptide oxytocin analogue |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9604341D0 true SE9604341D0 (sv) | 1996-11-26 |
Family
ID=20404757
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9604341A SE9604341D0 (sv) | 1996-11-26 | 1996-11-26 | Hepta-peptide oxytocin analogue |
Country Status (35)
Country | Link |
---|---|
US (1) | US6143722A (xx) |
EP (1) | EP0938496B1 (xx) |
JP (1) | JP3405460B2 (xx) |
KR (1) | KR100463132B1 (xx) |
CN (1) | CN1129606C (xx) |
AR (1) | AR008531A1 (xx) |
AT (1) | ATE242264T1 (xx) |
AU (1) | AU713424B2 (xx) |
BR (1) | BR9713366B1 (xx) |
CA (1) | CA2272990C (xx) |
CZ (1) | CZ299532B6 (xx) |
DE (1) | DE69722651T2 (xx) |
DK (1) | DK0938496T3 (xx) |
EE (1) | EE03832B1 (xx) |
ES (1) | ES2203823T3 (xx) |
HK (1) | HK1022481A1 (xx) |
HR (1) | HRP970630B1 (xx) |
HU (1) | HU228568B1 (xx) |
IL (1) | IL129519A (xx) |
LT (1) | LT4650B (xx) |
LV (1) | LV12350B (xx) |
MY (1) | MY125555A (xx) |
NO (1) | NO321380B1 (xx) |
NZ (1) | NZ336445A (xx) |
PL (1) | PL189292B1 (xx) |
PT (1) | PT938496E (xx) |
RO (1) | RO120772B1 (xx) |
RU (1) | RU2180668C2 (xx) |
SE (1) | SE9604341D0 (xx) |
SI (1) | SI20026B (xx) |
SK (1) | SK283800B6 (xx) |
TR (1) | TR199901028T2 (xx) |
UA (1) | UA54459C2 (xx) |
WO (1) | WO1998023636A1 (xx) |
ZA (1) | ZA9710518B (xx) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2181297C2 (ru) * | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
US6476072B1 (en) * | 2000-11-21 | 2002-11-05 | Arthur Vanmoor | Method of treating menstrual pain by enhancing the effectiveness of the human immune system |
EP1480998B1 (en) * | 2002-02-27 | 2006-11-22 | Ferring BV | Intermediates and methods for making heptapeptide oxytocin analogues |
AU2003229735A1 (en) * | 2002-05-02 | 2003-11-17 | Bayer Aktiengesellschaft | Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr) |
GB0210397D0 (en) * | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
UA76639C2 (uk) * | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій |
DK1530967T3 (da) * | 2003-11-13 | 2006-07-03 | Ferring Bv | Blisterpakning og dertil hörende fast dosisform |
EP1555029A1 (en) | 2004-01-19 | 2005-07-20 | Ferring B.V. | Use of substances having oxytocin antagonistic properties for the preparation of a medicament for treating hypertension |
US20060171909A1 (en) * | 2005-02-03 | 2006-08-03 | The Procter & Gamble Company | Cosmetic compositions comprising colorants with low free dye |
SE0600482L (sv) * | 2006-03-02 | 2006-11-14 | Ferring Int Ct Sa | Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse |
AU2008283929B2 (en) | 2007-08-06 | 2013-10-10 | Serenity Pharmaceuticals, Llc | Methods and devices for desmopressin drug delivery |
AU2009233429B2 (en) * | 2008-03-31 | 2014-02-13 | Ferring B.V. | Oxytocin analogues |
US20100286045A1 (en) | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
EP2712622B1 (en) | 2008-05-21 | 2016-07-13 | Ferring B.V. | Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia |
US11963995B2 (en) | 2008-05-21 | 2024-04-23 | Ferring B.V. | Methods comprising desmopressin |
TWI463990B (zh) * | 2009-09-21 | 2014-12-11 | Ferring Bv | 催產素受體促進劑 |
SG187038A1 (en) | 2010-07-15 | 2013-02-28 | Oleg Iliich Epshtein | A method of increasing the effect of an activated-potentiated form of an antibody |
JO3400B1 (ar) * | 2010-09-30 | 2019-10-20 | Ferring Bv | مركب صيدلاني من كاربيتوسين |
WO2012121057A1 (ja) | 2011-03-09 | 2012-09-13 | Jitsubo株式会社 | 新規な非ペプチド性架橋構造を含む架橋ペプチド、ならびに該架橋ペプチドの合成方法および該方法に用いる新規な有機化合物 |
CN102875650B (zh) * | 2012-09-26 | 2014-06-11 | 深圳翰宇药业股份有限公司 | 巴卢西班的制备方法 |
US9365615B2 (en) | 2013-09-09 | 2016-06-14 | Jitsubo Co., Ltd. | Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method |
EP3501533A1 (en) | 2014-12-22 | 2019-06-26 | Ferring B.V. | Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies |
US9937223B2 (en) | 2015-01-30 | 2018-04-10 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9744239B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9687526B2 (en) | 2015-01-30 | 2017-06-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9925233B2 (en) | 2015-01-30 | 2018-03-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9744209B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9750785B2 (en) | 2015-01-30 | 2017-09-05 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
CN108290929A (zh) | 2015-10-06 | 2018-07-17 | 辉凌公司 | 制造巴芦西班及其中间体的新型方法 |
AU2017205670B2 (en) | 2016-01-04 | 2021-05-20 | Merck Serono S.A. | L-valinate of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof |
CA3031252A1 (en) | 2016-07-21 | 2018-01-25 | ObsEva S.A. | Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage |
EP4025207A1 (en) | 2019-09-03 | 2022-07-13 | ObsEva S.A. | Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage |
US20230102503A1 (en) | 2020-02-10 | 2023-03-30 | ObsEva S.A. | Biomarkers for oxytocin receptor antagonist therapy |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2036973A1 (en) * | 1990-02-27 | 1991-08-28 | Mark G. Bock | Cyclic hexapeptide oxytocin antagonists |
SE9002384D0 (sv) * | 1990-07-09 | 1990-07-09 | Ferring Ab | Derivat av baklobshormoner |
SE501678C2 (sv) * | 1993-07-13 | 1995-04-10 | Ferring Bv | Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid |
SE523819C2 (sv) | 1994-01-27 | 2004-05-18 | Per-Ingvar Nilsson | Accelerationsmunstycke samt metod för dess användning |
SE9400918L (sv) | 1994-03-18 | 1995-09-19 | Anne Fjellstad Paulsen | Stabiliserad komposition för oral administrering av peptider |
SE9500249L (sv) | 1995-01-25 | 1996-03-25 | Valeo Engine Cooling Ab | Värmeväxlartank med ändstycken, förfarande för framställning av en sådan tank, samt värmeväxlare försedd med en sådan |
-
1996
- 1996-11-26 SE SE9604341A patent/SE9604341D0/xx unknown
-
1997
- 1997-11-21 ZA ZA9710518A patent/ZA9710518B/xx unknown
- 1997-11-21 SK SK704-99A patent/SK283800B6/sk not_active IP Right Cessation
- 1997-11-21 JP JP52460298A patent/JP3405460B2/ja not_active Expired - Lifetime
- 1997-11-21 RU RU99113364/04A patent/RU2180668C2/ru active
- 1997-11-21 IL IL12951997A patent/IL129519A/en not_active IP Right Cessation
- 1997-11-21 WO PCT/SE1997/001968 patent/WO1998023636A1/en active IP Right Grant
- 1997-11-21 DK DK97946210T patent/DK0938496T3/da active
- 1997-11-21 SI SI9720076A patent/SI20026B/sl unknown
- 1997-11-21 UA UA99042410A patent/UA54459C2/uk unknown
- 1997-11-21 ES ES97946210T patent/ES2203823T3/es not_active Expired - Lifetime
- 1997-11-21 DE DE69722651T patent/DE69722651T2/de not_active Expired - Lifetime
- 1997-11-21 TR TR1999/01028T patent/TR199901028T2/xx unknown
- 1997-11-21 AT AT97946210T patent/ATE242264T1/de active
- 1997-11-21 CA CA002272990A patent/CA2272990C/en not_active Expired - Lifetime
- 1997-11-21 HR HR970630A patent/HRP970630B1/xx not_active IP Right Cessation
- 1997-11-21 HU HU0000577A patent/HU228568B1/hu unknown
- 1997-11-21 BR BRPI9713366-3A patent/BR9713366B1/pt not_active IP Right Cessation
- 1997-11-21 NZ NZ336445A patent/NZ336445A/en not_active IP Right Cessation
- 1997-11-21 AU AU51429/98A patent/AU713424B2/en not_active Expired
- 1997-11-21 CZ CZ0183299A patent/CZ299532B6/cs not_active IP Right Cessation
- 1997-11-21 KR KR10-1999-7004449A patent/KR100463132B1/ko not_active IP Right Cessation
- 1997-11-21 EP EP97946210A patent/EP0938496B1/en not_active Expired - Lifetime
- 1997-11-21 PL PL97333876A patent/PL189292B1/pl unknown
- 1997-11-21 RO RO99-00593A patent/RO120772B1/ro unknown
- 1997-11-21 PT PT97946210T patent/PT938496E/pt unknown
- 1997-11-21 EE EEP199900210A patent/EE03832B1/xx unknown
- 1997-11-21 CN CN97180014A patent/CN1129606C/zh not_active Expired - Fee Related
- 1997-11-21 US US09/308,912 patent/US6143722A/en not_active Expired - Lifetime
- 1997-11-25 MY MYPI97005691A patent/MY125555A/en unknown
- 1997-11-26 AR ARP970105543A patent/AR008531A1/es active IP Right Grant
-
1999
- 1999-04-30 LV LVP-99-77A patent/LV12350B/en unknown
- 1999-05-11 LT LT99-052A patent/LT4650B/lt not_active IP Right Cessation
- 1999-05-26 NO NO19992532A patent/NO321380B1/no not_active IP Right Cessation
-
2000
- 2000-03-07 HK HK00101422A patent/HK1022481A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9604341D0 (sv) | Hepta-peptide oxytocin analogue | |
MX9801716A (es) | Derivados de meta-guanidina, urea, tiourea o acido aminobenzoico azaciclico, como antagonistas de integrina. | |
DE69705300T2 (de) | Cyclopropylalkansäurederivate | |
TW363064B (en) | Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors | |
DK0894084T3 (da) | Kanelsyrederivater og deres anvendelse som integrinantagonister | |
ES2162676T3 (es) | Derivados de fenileno sustituidos en meta y su uso como antagonistas o inhibidores de integrina alfav,beta3. | |
ATE260658T1 (de) | Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen | |
ES2137998T3 (es) | Nuevos derivados de aminoacidos, procedimiento para su preparacion y composiciones farmaceuticas que contienen estos compuestos. | |
HUP9901209A2 (hu) | Opioid analóg peptid vegyületek, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények | |
MC2326A1 (fr) | Antagonistes d'un nonapeptide de la bombesine | |
ATE245435T1 (de) | Totalsynthese des amino hip analogen von didemnin a | |
NO944293D0 (no) | Bombesin antagonist-polypeptider | |
MX9201055A (es) | N-[[4,5-dihidroxi- y 4,5,8-trihidroxi-9,10-dihidro-9,10-dioxo-2-antracen-il] carbonil] aminoacidos utiles en la terapia de afecciones osteoarticulares. | |
DE69119409D1 (de) | Vasoaktive derivate des vasotocins | |
SE9800865D0 (sv) | New Process | |
BR0113671A (pt) | Antagonistas de integrina alfa v beta 3 gem-substituìda |